| scholarly article | Q13442814 |
| P2093 | author name string | Blake DR | |
| Unsworth J | |||
| Lunec J | |||
| Sturman S | |||
| P2860 | cites work | Non-steroidal analgesic and anti-inflammatory agents. | Q34993117 |
| Pharmacology of nonsteroidal anti-inflammatory drugs. Practical review for clinicians | Q40162230 | ||
| The role of prostaglandins in the control of renal function: renal effects of nonsteroidal anti-inflammatory drugs. | Q40216094 | ||
| Prostaglandins: Modulators of Renal Function and Pressor Resistance in Chronic Liver Disease* | Q41630459 | ||
| Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects | Q42261455 | ||
| Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus | Q44251728 | ||
| Nonsteroidal anti-inflammatory drugs and renal disease. | Q53894158 | ||
| Non-steroidal anti-inflammatory drugs and renal failure | Q69874854 | ||
| Acute and chronic effects of sulindac on renal function in chronic renal disease | Q70058803 | ||
| Present and future of the nonsteroidal anti-inflammatory drugs in nephrology | Q70352497 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 233-236 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Renal impairment associated with non-steroidal anti-inflammatory drugs | |
| P478 | volume | 46 |
| Q28360066 | A prospective study of renal disease in patients with early rheumatoid arthritis |
| Q68097368 | A survey of renal function in outpatients with rheumatoid arthritis |
| Q54102793 | An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritis. |
| Q38192207 | Clinical biochemical measurements in rheumatology |
| Q74223361 | Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis |
| Q43797278 | Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications |
| Q33562630 | Drug toxicity |
| Q73457086 | Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis |
| Q58873968 | Electroanalysis of Cytochrome P450 3A4 Catalytic Properties with Nanostructured Electrodes: The Influence of Vitamin B Group on Diclofenac Metabolism |
| Q68037779 | Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis |
| Q36510279 | Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues |
| Q68506534 | Nonsteroidal anti-inflammatory drugs |
| Q24235971 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity |
| Q74798758 | Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications |
| Q40775893 | Renal complications of nonsteroidal anti-inflammatory drugs |
| Q41250891 | Renal impairment associated with non-steroidal anti-inflammatory drugs |
| Q33560790 | Renal impairment in relation to non-steroidal anti-inflammatory drugs |
| Q38763470 | The kidney in rheumatic diseases |
| Q34776806 | The management of hyperuricemia and gout in patients with heart failure |
| Q35705238 | Toxic interaction of lithium carbonate and mefenamic acid |
Search more.